Grant: Engage Grants Program
University of Calgary
$25,000.00
Assessment of the CRISPR technology in tobacco for therapeutic protein production
EF 2015-16
Résumé
The PlantForm Corporation has developed tobacco as a platform to produce therapeutic antibodies. Plant has
an advantage over microbes in manufacturing recombinant antibodies because plant can catalyze
N-glycosylations to add sugars on the proteins as mammalian cells do. However, two plant-unique sugars,
namely fucose and xylose, are also incorporated to the recombinant antibodies. These two sugars are
undesirable in the antibodies as they can cause allergic reactions in human. These sugars are added to the
antibodies by fucosyl and xylosyl transferase enzymes in plant. To overcome this problem, the PlantForm has
utilized the RNA interference (RNAi) to reduce fucosyl and xylosyl transferase mRNAs, but a small percentage
(<1%) of the antibodies still possess these undesirable sugar groups. It is therefore important to entirely
eliminate the fucosyl and xylosyl transferase activities in tobacco by other means. This proposal focuses on
assessing the possibility of generating a mutant tobacco, deficient of fucosyl and xylosyl transferase activities,
using the CRISPR (clustered regularly interspaced short palindromic repeats) technology. CRISPR is a newly
developed molecular method which can generate deletion-mutations on targeted loci in eukaryotic genomes.
Genomics analysis of the tobacco plant identified three pairs of highly homologous fucosyl and xylosyl
transferases (one pair of xylosyl transferase and two pairs of fucosyl transferases). These three gene pairs will
be targeted for deletions by CRISPR. Specifically, we will constructs multiple CRISPR components in
plasmids and transiently express these in tobacco leaves. Genomic DNAs will be isolated from the leaves, and
targeted loci will be amplified by PCR. Using sequencing and bioinformatics, presence and frequency of the
deletion mutations in the amplified loci will be determined for each CRISPR construct. These results will
provide knowledge to the PlantForm about whether the genes encoding fucosyl and xylosyl transferase can be
permanently deleted by CRISPR and what CRISPR constructs operate most efficiently.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
478461-2015
Name nom
Ro, DaeKyun
Department département
Biological Sciences
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
500
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Manufacturing processes and products
Area of application fr
Procédés et produits industriels
Research subject code
4901
Research subject group en
Plant and treebiology
Research subject group fr
Biologie végétale et des arbres
Research subject en
Nutrition and metabolism, photosynthesis
Research subject fr
Nutrition et métabolisme, photosynthèse
Partie
1
Nb partie
1
Application title
Assessment of the CRISPR technology in tobacco for therapeutic protein production
Keyword
NSERC
Application summary
The PlantForm Corporation has developed tobacco as a platform to produce therapeutic antibodies. Plant has
an advantage over microbes in manufacturing recombinant antibodies because plant can catalyze
N-glycosylations to add sugars on the proteins as mammalian cells do. However, two plant-unique sugars,
namely fucose and xylose, are also incorporated to the recombinant antibodies. These two sugars are
undesirable in the antibodies as they can cause allergic reactions in human. These sugars are added to the
antibodies by fucosyl and xylosyl transferase enzymes in plant. To overcome this problem, the PlantForm has
utilized the RNA interference (RNAi) to reduce fucosyl and xylosyl transferase mRNAs, but a small percentage
(<1%) of the antibodies still possess these undesirable sugar groups. It is therefore important to entirely
eliminate the fucosyl and xylosyl transferase activities in tobacco by other means. This proposal focuses on
assessing the possibility of generating a mutant tobacco, deficient of fucosyl and xylosyl transferase activities,
using the CRISPR (clustered regularly interspaced short palindromic repeats) technology. CRISPR is a newly
developed molecular method which can generate deletion-mutations on targeted loci in eukaryotic genomes.
Genomics analysis of the tobacco plant identified three pairs of highly homologous fucosyl and xylosyl
transferases (one pair of xylosyl transferase and two pairs of fucosyl transferases). These three gene pairs will
be targeted for deletions by CRISPR. Specifically, we will constructs multiple CRISPR components in
plasmids and transiently express these in tobacco leaves. Genomic DNAs will be isolated from the leaves, and
targeted loci will be amplified by PCR. Using sequencing and bioinformatics, presence and frequency of the
deletion mutations in the amplified loci will be determined for each CRISPR construct. These results will
provide knowledge to the PlantForm about whether the genes encoding fucosyl and xylosyl transferase can be
permanently deleted by CRISPR and what CRISPR constructs operate most efficiently.